首页 | 本学科首页   官方微博 | 高级检索  
     

小剂量卡维地洛对急性心肌梗死后患者心室重构的影响
引用本文:王雪梅,岳锦亮,王凤楼,王彬. 小剂量卡维地洛对急性心肌梗死后患者心室重构的影响[J]. 海南医学, 2009, 20(9): 9-11
作者姓名:王雪梅  岳锦亮  王凤楼  王彬
作者单位:天津市宁河县医院,天津,宁河,301500;天津市宁河县医院,天津,宁河,301500;天津市宁河县医院,天津,宁河,301500;天津市宁河县医院,天津,宁河,301500
摘    要:目的探讨小剂量卡维地洛(12.5mg/d)对急性心肌梗死后患者心室重构的影响。方法急性心肌梗死患者60例,根据心电图表现将病例分为前壁心肌梗死组(N=42)和下壁心肌梗死组(N=18),均于急性心肌梗死后24—48小时内给予卡维地洛3.125mg×2/日口服,2周后加量为6.25mg×2/日。分别于心肌梗死后1周及25周时记录病人心率、血压,并进行心脏超声检查测量其左心房前后径(LA)、左室舒张末内径(LVEDD)、左室射血分数(LVEF)、左室短轴缩短率(FS)。结果与第1周相比,第25周时病人LA、LVEDD均明显减低(44.22±4.76mm vs39.47±4.45mm;59.53±5.25mm vs 53.50±4.28mm,均P〈0.001),LVEF、FS明显增加(46.10±6.69%vs56.42±6.14%,P〈0.001;9.28±3.32%vs20.79±4.65%,P〈0.05)。前壁心肌梗死组病人LVEDD明显大于下壁心肌梗死组(60.57±5.44mm vs 57.11±3.92mm,P〈0.05),LVEF明显较下壁心肌梗死组低(44.79±6.68%vs 49.17±5.77%,P〈0.05)。25周时,前壁心肌梗死组病人心室重构改善明显好于下壁心肌梗死组。LVEDD缩小值(6.48±2.74mm vs5.00±2.09mm,P〈0.05)、LVEF提高值(10.93±5.15%vs 8.89±2.52%,P〈0.05),前壁心肌梗死组均较下壁心肌梗死组明显。结论卡维地洛(12.5ms/d)作为靶剂量可明显改善急性心肌梗死后左室重塑,有良好的安全性和耐受性,且对于前壁心肌梗死更为必要和有效。

关 键 词:小剂量卡维地洛  心室重构

Effect of low-dose carvedilol on ventricular remodeling after acute myocardial infarction
Affiliation:WANG Xue - mei, YUE Jin-liang, WANG Feng- lou, et al.( Cardiovascular department, Tionjin Ninghe Hospital, Tianjin 301500, P. R. CHINA )
Abstract:Objective To investigate the effect of low - dose earvedilol (12.5rag/d) on ventricular remodeling after acute myocardial infarction(AMI). Methods 60 AMI patients were divided into anterior AMI group and inferior AMI group based on ECG. The dose of 6.25mg/d earvedilol was administrated which would increase to 12. 5mg/d after 2 weeks if it can be tolerated. The heart rate, blood pressure were recorded and the echocardio-graphs were measured to obtain the left atrial diameter( LA), left ventrieular end - diastolic diameter( LVEDD), left ventrieular ejection fraction( LVEF), and left ventrieular shortening fraction(FS). Results At 25 weeks, patients' LA and LVEDD deereased(44.22 ± 4.76mm vs 39.47±4.45mm; 59.53 ± 5.25mm vs 53.50 ± 4.28mm, P〈0.001) and the LVEF and FS increased (46.10 ±6.69% vs 56.42 ±6.14%, P 〈0.001 ; 9.28 ±3.32% vs 20.79 ±4.65%, P 〈0.05 ). LVEDD was larger in anterior AMI group than that in inferior AMI group (60.57 ± 5.44mm vs 57.11± 3.92mm, P 〈 0.05 ) at 1 week, while LVEF lower (44.79± 6.68% vs 49.17 ± 5.77%, P 〈 0.05 ). At 25 weeks, the LVEDD of anterior AMI group decreased more than inferior AMI group (6.48 ± 2.74mm vs 5.00 ±2.09mm, P 〈 0.05), while the LVEF increased more ( 10.93 ± 5.15% vs 8.89 ± 2.52% , P 〈 0.05 ). Conclusion The dose of carvedilol (12.5mg/d) has the beneficial effect on ventricular remodeling after AMI. It is more necessary and effective for anterior AMI patients.
Keywords:Low - dose Carvedilol  Ventricular reeodeling
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号